C4 Therapeutics, Inc. (CCCC)
2.92
-0.05
(-1.68%)
USD |
NASDAQ |
May 06, 16:00
2.92
0.00 (0.00%)
After-Hours: 20:00
C4 Therapeutics EPS Diluted (Quarterly) : -0.1754 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.00 |
| Biogen, Inc. | 2.153 |
| Merck & Co., Inc. | -1.715 |
| Bristol Myers Squibb Co. | 1.308 |
| BrightSpring Health Services, Inc. | 0.3363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.49M |
| Revenue (Quarterly) | 11.02M |
| Total Expenses (Quarterly) | 31.50M |
| Enterprise Value | 101.25M |
| Gross Profit Margin (Quarterly) | 83.61% |
| Profit Margin (Quarterly) | -186.0% |
| Earnings Yield | -46.46% |
| Normalized Earnings Yield | -42.92 |